SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Trading Update

29 Jan 2009 16:04

RNS Number : 4846M
Gooch & Housego PLC
29 January 2009
 



For immediate release 

29 January 2009

Gooch & Housego PLC

(The "Company")

Trading Update

Gooch & Housego PLC, the specialist manufacturer of optical components and systems, today announces that it has experienced a sudden and significant drop in demand for certain of its products with the result that earnings for the year to 30 September 2009 are likely to be materially lower than the Board's original expectations for the current financial year. 

The most significant impact has been felt in the Company's key Acousto-Optics & Electro-Optics business unit where demand for acousto-optic Q-switches for general industrial, semiconductor and microelectronic applications has decreased by between a quarter and a half depending on the end user market. Whilst the order book remains strong, customers are significantly reducing their monthly requirements as they experience a similar reduction in demand for their laser systems. The effect is being felt on a global basis with the US, European and Asia-Pacific markets all affected. Indications are that demand will remain depressed for the foreseeable future.

Other sectors of the business, particularly those serving the aerospace, defence and life sciences markets have been less affected. The Company's Precision Optics, Fibre Optics and Instrumentation & Life Sciences business units are all trading broadly in line with the Board's original expectations for the current financial year.

In view of the decrease in sales steps are being taken to realign the cost base of the Company with the greatest savings taking place in the Acousto-Optics & Electro-Optics business unit.

The Company has been impacted by the recent rapid decline in the value of Sterling against the US Dollar and to a lesser extent the Euro. More than 85% of Company revenues are denominated in currencies other than Sterling with the US Dollar accounting for approximately 79% and the Euro approximately 6% with proportionately higher level of Company profits associated with the US Dollar.

The effect of the decline in the value of Sterling particularly against the US Dollar will to some extent offset the anticipated decrease in revenues at the Company's key Acousto-Optics & Electro-Optics business unit.

However, the Company's borrowings are predominantly denominated in US Dollars with approximately 85% of total borrowings in US Dollars and the balance in SterlingWhilst the US Dollar borrowings provide a natural hedge given the Company's significant US Dollar asset base and the high proportion of US Dollar revenues and profits, the fall in the value of Sterling against the US Dollar has the effect of increasing the magnitude of the Company's debt when translated into Sterling

Consequently, the Company is in discussions with its bankersThe Royal Bank of Scotland plcconcerning the impact of these currency issues that affect, and may continue to affect, certain bank covenant calculations. 

The Board is confident that the Company will meet its bank interest and debt repayment obligations to its bankers as they fall due. 

The Company believes that it is not appropriate to finalise its accounts for the year ended 30 September 2008 until the discussions with its bankers have been satisfactorily completed. Following completion of these discussions, the date of the Company's Annual General Meeting will be announced.

For further information, please contact:

Gareth Jones, Chief Executive Officer, 01460 256440

Peter J. Quinn, Chief Financial Officer, 01460 256446

Tim Thompson/Chris McMahon, Buchanan Communications Ltd, 020 7466 5000

Patrick Robb, Investec Bank (UK) Ltd, 020 7597 5169

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEDFMUSUSESF
Date   Source Headline
3rd Jun 20267:00 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim Results
20th May 20267:00 amRNSNotice of Half Year Results
10th Apr 20262:25 pmRNSHolding(s) in Company
9th Apr 20267:00 amRNSHalf Year Trading Update
20th Mar 20263:16 pmRNSHolding(s) in Company
27th Feb 20262:23 pmRNSResult of AGM
27th Feb 20267:00 amRNSAGM Trading Update
2nd Feb 20267:00 amRNSChief Financial Officer appointment date
22nd Jan 20262:26 pmRNSHolding(s) in Company
13th Jan 20264:41 pmRNSHolding(s) in Company
12th Jan 20264:34 pmRNSPDMR notice
12th Jan 20263:30 pmRNSGrant of LTIP awards
9th Jan 20267:00 amRNSPDMR Notice and Issue of Equity
7th Jan 20267:00 amRNSPosting of Annual Report and Notice of AGM
12th Dec 20257:00 amRNSAppointment of Chief Financial Officer
2nd Dec 202511:36 amRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSResults for the year ended 30 September 2025
25th Nov 20257:00 amRNSNotification of Full Year Results
20th Nov 20252:14 pmRNSHolding(s) in Company
4th Nov 20257:07 amRNSDirectorate Update
8th Oct 20257:00 amRNSFurther Issue of Shares and TVR
7th Oct 20257:00 amRNSFull Year Trading Update
1st Oct 20252:15 pmRNSHolding(s) in Company
21st Jul 20257:00 amRNSChief Financial Officer Transition
15th Jul 20255:08 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSNotification of Major Holdings
23rd Jun 20252:30 pmRNSHolding(s) in Company - Replacement
20th Jun 202512:08 pmRNSHolding(s) in Company
18th Jun 20257:00 amRNSCompletion of Acquisition & Total Voting Rights
3rd Jun 20257:00 amRNSInterim Results
20th May 20257:00 amRNSNotification of Half Year Results
14th May 20257:00 amRNSAcquisition of Global Photonics
9th Apr 20252:16 pmRNSHolding(s) in Company
8th Apr 20257:00 amRNSHalf Year Trading Update
24th Feb 20252:19 pmRNSResult of AGM
24th Feb 20257:00 amRNSAGM Trading Update
7th Jan 20252:58 pmRNSGrant of LTIP Awards
6th Jan 202511:15 amRNSPosting of Annual Report and Notice of AGM
20th Dec 20243:15 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSResults for the year ended 30 September 2024
4th Nov 20247:00 amRNSNotification of Full Year Results
30th Oct 20247:00 amRNSAcquisition of Phoenix Optical
28th Oct 20242:35 pmRNSHolding(s) in Company
8th Oct 20247:00 amRNSFull Year Trading Update
26th Sep 202410:31 amRNSDirector/PDMR Shareholding
23rd Aug 202412:52 pmRNSNotification of Major Holdings
16th Aug 20245:46 pmRNSHolding(s) in Company
16th Aug 20244:49 pmRNSHolding(s) in Company
15th Aug 20244:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.